Literature DB >> 4356456

Suppression of herpes simplex virus infection by phosphonoacetic acid.

N L Shipkowitz, R R Bower, R N Appell, C W Nordeen, L R Overby, W R Roderick, J B Schleicher, A M Von Esch.   

Abstract

Disodium phosphonoacetate when administered orally or topically to mice experimentally infected with herpes simplex virus was able to significantly reduce the mortality associated with the agent. In addition, this compound was able to reduce herpesvirus lesions on the corneas of infected rabbits.

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4356456      PMCID： PMC379771          DOI： 10.1128/am.26.3.264-267.1973

Source DB:  PubMed          Journal:  Appl Microbiol        ISSN： 0003-6919


  24 in total

1.  Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, other head and neck neoplasms, and control groups.

Authors:  W Henle; G Henle; H C Ho; P Burtin; Y Cachin; P Clifford; A de Schryver; G de-Thé; V Diehl; G Klein
Journal:  J Natl Cancer Inst       Date:  1970-01       Impact factor: 13.506

2.  Herpes simplex virus pneumonia. Occurrence in an allotransplanted lung.

Authors:  R G Douglas; S Anderson; J G Weg; T Williams; D E Jenkins; V Knight; A C Beall
Journal:  JAMA       Date:  1969-11-03       Impact factor: 56.272

3.  Peculiarities of the antiviral action of dibenzylphosphinic acid.

Authors:  A D Inglot; M Kochman; P Mastalerz; A Pelczarska
Journal:  Acta Virol       Date:  1967-05       Impact factor: 1.162

4.  Activity of salicylates as inhibitors of virus replication in vitro and their mode of action.

Authors:  A D Inglot; M Kochman; P Mastalerz
Journal:  Acta Virol       Date:  1966-05       Impact factor: 1.162

5.  The effect of 5-iodo-2'-deoxyuridine on herpes simplex virus infections in guinea-pig skin.

Authors:  A H Tomlinson; F O Maccallum
Journal:  Br J Exp Pathol       Date:  1968-06

6.  Antiviral activity of p-nitrobenzylphosphonic acid.

Authors:  A D Inglot; M Kochman; P Mastalerz
Journal:  Nature       Date:  1965-08-14       Impact factor: 49.962

7.  Inhibition of encephalomyocarditis virus replication by simple phosphonic and carboxylic acids.

Authors:  M Kochman; P Mastalerz; A D Inglot
Journal:  Nature       Date:  1965-08-21       Impact factor: 49.962

8.  Common external ocular infections.

Authors:  J H Allen
Journal:  Postgrad Med       Date:  1969-05       Impact factor: 3.840

9.  The association of herpesvirus type 2 and carcinoma of the uterine cervix.

Authors:  W E Rawls; W A Tompkins; J L Melnick
Journal:  Am J Epidemiol       Date:  1969-05       Impact factor: 4.897

10.  Antibodies to Herpesvirus hominis types 1 and 2 in humans. II. Women with cervical cancer.

Authors:  A J Nahmias; W E Josey; Z M Naib; C F Luce; B A Guest
Journal:  Am J Epidemiol       Date:  1970-06       Impact factor: 4.897
View more
  46 in total

1.  Inhibition of herpes simplex virus replication by phosphonoacetic acid.

Authors:  L R Overby; E E Robishaw; J B Schleicher; A Rueter; N L Shipkowitz; J C Mao
Journal:  Antimicrob Agents Chemother       Date:  1974-09       Impact factor: 5.191

2.  Efficacy of phosphonoacetic acid on herpes simplex virus infection of sensory ganglia.

Authors:  C R Wohlenberg; M A Walz; A L Notkins
Journal:  Infect Immun       Date:  1976-05       Impact factor: 3.441

3.  Differential effect of phosphonoacetic acid on the expression of Epstein-Barr viral antigens and virus production.

Authors:  O Nyormoi; D A Thorley-Lawson; J Elkington; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1976-05       Impact factor: 11.205

4.  Phosphonoacetic acid in the treatment of experimental ocular herpes simplex infections.

Authors:  R F Meyer; E D Varnell; H E Kaufman
Journal:  Antimicrob Agents Chemother       Date:  1976-02       Impact factor: 5.191

5.  Phosphonoacetic acid-resistant herpes simplex virus infection in hairless mice.

Authors:  R J Klein; A E Friedman-Kien
Journal:  Antimicrob Agents Chemother       Date:  1975-03       Impact factor: 5.191

6.  Phosphonoacetic acid in the treatment of experimental herpes simplex keratitis.

Authors:  D D Gerstein; C R Dawson; J O O
Journal:  Antimicrob Agents Chemother       Date:  1975-03       Impact factor: 5.191

7.  Deoxyribonucleic acid polymerase of wild-type and phosphonoacetic acid-resistant mutant of herpes simplex virus.

Authors:  B Fridlender; N Chejanovsky; Y Becker
Journal:  Antimicrob Agents Chemother       Date:  1978-01       Impact factor: 5.191

8.  Purification and characterization of varicella-zoster virus-induced DNA polymerase.

Authors:  E C Mar; Y S Huang; E S Huang
Journal:  J Virol       Date:  1978-05       Impact factor: 5.103

9.  Inhibition of herpesvirus replication and herpesvirus-induced deoxyribonucleic acid polymerase by phosphonoformate.

Authors:  J M Reno; L F Lee; J A Boezi
Journal:  Antimicrob Agents Chemother       Date:  1978-02       Impact factor: 5.191

10.  Alteration of mortality and pathogenesis of three experimental Herpesvirus hominis infections of mice with adenine arabinoside 5'-monophosphate, adenine arabinoside, and phosphonoacetic acid.

Authors:  E R Kern; J T Richards; J C Overall; L A Glasgow
Journal:  Antimicrob Agents Chemother       Date:  1978-01       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.